AlphaStocks
5.8
Consider Buy

Waters Corp (WAT)

As of Sep 21, 2026, Waters Corp (WAT) scores 5.8/10 on AlphaStocks' five-model composite, #64 of 168 Health Care stocks. At $422, WAT trades 60% above its model fair value of $263.

Health Care / Life Sciences Tools & Services

S&P 500

$421.66

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 21, 2026

#64out of 168 in Health Care

Is WATERS CORP /DE/ a Good Investment in 2026?

WATERS CORP /DE/ (WAT) scores 5.8 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model is the most favorable, rating WATERS CORP /DE/ as Neutral. However, the Graham model rates it Caution — 83% above fair value. WATERS CORP /DE/ currently trades 60% above its estimated fair value of $263. WATERS CORP /DE/ ranks #64 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E39.2ROE6.2Market Cap25B

Estimated Fair Value

$263.2960% above

Trading above estimated fair value. P/e of 39x implies high growth expectations.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

83% above fair value

Lynch

Neutral

PEG 4.0 · Stalwart

Greenblatt

Neutral

Earnings yield 3.4% · ROC 52%

Frequently Asked Questions

Is WATERS CORP /DE/ (WAT) a good investment?
As of Sep 21, 2026, Waters Corp (WAT) scores 5.8/10 on AlphaStocks' five-model composite, #64 of 168 Health Care stocks. At $422, WAT trades 60% above its model fair value of $263. That is a middle-of-the-pack score with no strong signal either way.
What is WATERS CORP /DE/'s Piotroski F-Score?
WATERS CORP /DE/'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is WAT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $263, WAT appears overvalued. The stock currently trades 60% above its estimated fair value. Trading above estimated fair value. P/e of 39x implies high growth expectations.
How does WAT compare to other Health Care stocks?
WATERS CORP /DE/ ranks #64 out of 168 stocks in the Health Care sector, placing it in the top 38% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about WAT?
AlphaStocks evaluates WAT using five proven investment models. Piotroski: Neutral; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 5.8/10.

Similar Stocks

BIOILMNAZTA

Compare WAT with

BIO vs WATILMN vs WATAZTA vs WATVAL vs WAT

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer